Back to dashboard
Episode 674
DIP Ep 674: USMLE Pharm Crash Course, The Drugs That Matter (Part 5)
Pharmacology
Medium
5 - Very High
High Yield
Step 1Step 2Step 3COMLEX
PHARMACOLOGYPSYCHIATRYANTIPSYCHOTICSANTIDEPRESSANTSSEROTONIN SYNDROMENMSLITHIUM
Topic
Psychiatric & Neurologic Pharmacology; Antidepressant classes (SSRIs, SNRIs, TCAs, MAOIs, Bupropion, Mirtazapine, Trazodone); Antipsychotics (First-Gen typicals vs Second-Gen atypicals); Serotonin Syndrome vs Neuroleptic Malignant Syndrome (NMS) vs Malignant Hyperthermia; Lithium toxicity, drug interactions & monitoring; Bipolar mood stabilizers; Extrapyramidal symptoms (EPS) timeline & management.
Key Takeaway
Psychiatric pharmacotherapy on the USMLE and COMLEX hinges on differentiating life-threatening toxidromes (Serotonin Syndrome with hyperreflexia/clonus vs NMS with lead-pipe rigidity and hyporeflexia) and managing critical adverse effects: Lithium renal clearance interactions (NSAIDs, Thiazides, ACEi), Clozapine agranulocytosis monitoring, and the EPS progression timeline (acute dystonia -> akathisia -> parkinsonism -> tardive dyskinesia).
Runtime: 23.8 min
Published: 2026-09-26
System: Pharmacology
Section: PHARMACOLOGY, PSYCHIATRY, NEUROLOGY
Episode Notes
Source / episode info
- Episode: 674
- Title: DIP Ep 674: USMLE Pharm Crash Course, The Drugs That Matter (Part 5)
- Published: 2026-09-26
- Source: DIP Ep 674: USMLE Pharm Crash Course, The Drugs That Matter (Part 5)
One-liner
Part 5 of the Pharmacology Crash Course covers the high-yield psychotropics: antidepressants, typical and atypical antipsychotics, life-threatening toxidromes (Serotonin Syndrome vs NMS), Lithium toxicity dynamics, and the extrapyramidal symptoms timeline.
High-yield summary
- Antidepressant Mechanics & Side Effect Profiles: SSRIs (Sertraline, Escitalopram) are first-line for MDD, GAD, OCD, and PTSD; primary adverse effects include sexual dysfunction and SIADH. SNRIs (Venlafaxine, Duloxetine) inhibit 5-HT and NE reuptake; can cause dose-dependent hypertension and treat diabetic peripheral neuropathy. Bupropion inhibits NE and DA reuptake with zero sexual dysfunction and promotes weight loss, but lowers the seizure threshold and is strictly contraindicated in bulimia, anorexia nervosa, and active seizure disorders. Mirtazapine (alpha-2 antagonist) causes marked sedation and appetite stimulation via H1 blockade, making it first-line for elderly depressed patients with insomnia and significant weight loss. Trazodone (5-HT2 and alpha-1 antagonist) causes priapism and sedation.
- Serotonin Syndrome vs Neuroleptic Malignant Syndrome (NMS): Serotonin Syndrome is caused by excessive central and peripheral serotonin (SSRIs + MAOIs, TCAs, Tramadol, Linezolid, MDMA, St. Johns Wort). Characterized by rapid onset (< 24 hours), neuromuscular hyperactivity with HYPERREFLEXIA, TREMOR, and SPONTANEOUS OR OCULAR CLONUS, bilateral mydriasis, diaphoresis, and hyperactive bowel sounds; treated with Cyproheptadine (5-HT2 antagonist). In contrast, NMS is triggered by central dopamine D2 receptor blockade (typical and atypical antipsychotics, antiemetics). Characterized by insidious onset (1–3 days), severe generalized "LEAD-PIPE" RIGIDITY, HYPOREFLEXIA, extreme hyperthermia (> 40°C), marked creatine kinase (CK) elevation, and leukocytosis; treated with Dantrolene and Bromocriptine.
- Lithium Pharmacology, Toxicity & Interactions: Narrow therapeutic index (0.6–1.2 mEq/L). Excreted almost entirely by renal filtration and reabsorbed proximally with sodium. Any physiological state or drug reducing GFR or causing sodium depletion triggers lithium retention and acute toxicity: Thiazide diuretics (highest risk by causing proximal Na+ and Li+ retention), NSAIDs (decrease afferent renal blood flow by inhibiting prostaglandins), and ACE inhibitors / ARBs. Classic acute toxicity presents with coarse tremors, ataxia, confusion, and dysarthria. Chronic toxicities include nephrogenic diabetes insipidus (impaired ADH response; treat with amiloride), primary hypothyroidism, and Ebstein anomaly in pregnancy.
- Antipsychotics & Extrapyramidal Symptoms (EPS) Timeline: First-generation typical antipsychotics (Haloperidol, Fluphenazine) strongly block D2 receptors. EPS follows a classic temporal progression: (1) 4 hours to days: Acute Dystonia (torticollis, oculogyric crisis; treat with anticholinergic Benztropine or Diphenhydramine); (2) 4 days to weeks: Akathisia (subjective inner motor restlessness; treat with Propranolol, Benztropine, or Lorazepam); (3) 4 weeks to months: Parkinsonism (cogwheel rigidity, masked facies, resting tremor; treat with Benztropine or Amantadine); (4) Months to years: Tardive Dyskinesia (involuntary choreoathetoid movements of face, tongue, and limbs; switch to clozapine/quetiapine and treat with VMAT2 inhibitors: Valbenazine, Deutetrabenazine; NEVER give anticholinergics!).
- Second-Generation Atypical Antipsychotics: Dual 5-HT2A and D2 antagonists with reduced EPS risk. Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia and reducing suicide risk; carries black-box warnings for agranulocytosis (mandatory absolute neutrophil count [ANC] monitoring: discontinue if ANC < 1,000/mcL), myocarditis, and seizure risk. Olanzapine carries the highest risk of metabolic syndrome and substantial weight gain. Ziprasidone carries the highest risk of QT prolongation. Risperidone causes the greatest degree of hyperprolactinemia (amenorrhea, galactorrhea, gynecomastia).
Learning objectives
- Differentiate Serotonin Syndrome from Neuroleptic Malignant Syndrome based on neuromuscular examination (clonus vs lead-pipe rigidity).
- Identify drug-drug interactions that precipitate acute Lithium toxicity (thiazides, NSAIDs, ACE inhibitors).
- Sequence and manage extrapyramidal symptoms chronologically from acute dystonia to tardive dyskinesia.
- Select antipsychotics based on metabolic, cardiac (QT prolongation), and hematologic safety profiles.
- Manage tricyclic antidepressant (TCA) cardiotoxicity with intravenous sodium bicarbonate.
Board exam buzzwords
| Psychotropic Class / Drug | Primary Mechanism of Action | High-Yield Clinical Application | Board Exam Adverse Effect / Trap |
|---|---|---|---|
| Bupropion | Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) | Depression without sexual dysfunction; smoking cessation | Contraindicated in bulimia/anorexia & seizure disorders (lowers seizure threshold). |
| Mirtazapine | Central alpha-2 adrenergic & 5-HT2/3 antagonist | Depressed geriatric patient with insomnia & severe weight loss | Marked sedation and hyperphagia/weight gain (antihistaminergic). |
| Trazodone | 5-HT2A/2C antagonist & 5-HT reuptake inhibitor, alpha-1 blocker | Insomnia in patients with depression or substance use disorder | Priapism (prolonged painful erection via alpha-1 blockade). |
| Clozapine | 5-HT2A and weak D2 antagonist | Treatment-resistant schizophrenia & persistent suicidal ideation | Agranulocytosis (mandatory ANC tracking), myocarditis, seizures. |
| Lithium | Inositol monophosphatase inhibition; alters intracellular signaling | Bipolar disorder maintenance & acute mania; anti-suicide | Nephrogenic DI, hypothyroidism, tremor, Ebstein anomaly (teratogen). |
| Amitriptyline / TCAs | Inhibits 5-HT & NE reuptake; blocks alpha-1, H1, mACh, fast Na+ | Neuropathic pain, migraine prophylaxis | Fatal arrhythmia via cardiac fast sodium channel blockade (wide QRS); treat with IV NaHCO3. |
Rapid review table
| Clinical Feature / Finding | Serotonin Syndrome | Neuroleptic Malignant Syndrome (NMS) | Malignant Hyperthermia (MH) |
|---|---|---|---|
| Inciting Pharmacotherapy | SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Linezolid, MDMA, St. Johns Wort | High-potency typical & atypical antipsychotics, Metoclopramide | Inhaled halogenated anesthetics (Sevoflurane) + Succinylcholine |
| Onset Timeline | Rapid (< 24 hours, often within hours of dose) | Insidious (1 to 3 days to weeks after exposure) | Hyperacute (minutes to hours during anesthesia) |
| Neuromuscular Tone & Reflexes | Hyperreflexia, spontaneous / ocular CLONUS, tremor | Severe diffuse "lead-pipe" rigidity, hyporeflexia | Severe generalized muscle contracture, masseter spasm |
| Pupillary & GI Findings | Bilateral mydriasis, hyperactive bowel sounds / diarrhea | Normal pupils, normal/hypoactive bowel sounds | Normal pupils, metabolic acidosis, rhabdomyolysis |
| Specific Antidote / Reversal | Cyproheptadine (5-HT2 receptor antagonist) | Dantrolene (RyR blocker) or Bromocriptine (DA agonist) | Dantrolene sodium (RyR1 receptor blocker) |
Board-speak -> diagnosis
| Vignette Clue | Target Concept / Diagnosis | Why It Fits |
|---|---|---|
| Vignette Clue | Target Concept / Diagnosis | Why It Fits |
| Depressed patient on sertraline takes OTC cough syrup (dextromethorphan) and presents with fever 39°C, agitation, bilateral ocular clonus, and hyperreflexia. | Serotonin Syndrome | Dextromethorphan has serotonergic activity; co-administration precipitates toxicity with diagnostic neuromuscular clonus. |
| Schizophrenic patient started on haloperidol 4 hours ago develops painful forced upward deviation of the eyes and lateral neck spasm. | Acute Dystonic Reaction (Oculogyric Crisis) | Acute dopaminergic blockade unmasks relative cholinergic excess; treated with anticholinergic Benztropine or Diphenhydramine. |
| Bipolar patient on lithium started on hydrochlorothiazide and ibuprofen develops coarse tremors, ataxia, confusion, and dysarthria. | Acute Lithium Toxicity | Thiazide diuretics and NSAIDs decrease renal lithium clearance, triggering toxic lithium accumulation. |
Management pearls
- In TCA overdose, the single most accurate predictor of fatal ventricular arrhythmia and seizure is QRS duration on ECG (> 100 ms predicts seizures, > 160 ms predicts ventricular arrhythmias). IV Sodium Bicarbonate narrows the QRS by overcoming competitive fast sodium channel blockade and increasing extracellular pH.
- Linezolid has weak nonselective MAO inhibitor activity; combining linezolid with SSRIs or SNRIs during treatment of MRSA or VRE frequently triggers life-threatening serotonin syndrome on board examinations.
- High-potency first-generation antipsychotics (Haloperidol, Fluphenazine) cause pronounced EPS and prolactin elevation with low anticholinergic side effects; low-potency agents (Chlorpromazine, Thioridazine) cause strong sedation, orthostatic hypotension, and corneal/retinal deposits.
Don't miss
🚨 Tardive Dyskinesia vs Acute EPS: Never administer anticholinergics (benztropine) for tardive dyskinesia—it significantly worsens symptoms! TD requires switching to an atypical with low D2 affinity (quetiapine/clozapine) and initiating a VMAT2 inhibitor (valbenazine, deutetrabenazine).
🚨 Clozapine Agranulocytosis Protocol: Clozapine is contraindicated if baseline absolute neutrophil count (ANC) is < 1,500/mcL (< 1,000 in benign ethnic neutropenia). Stop clozapine immediately if ANC drops below 1,000/mcL during therapy.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics & Biomechanics for COMLEX candidates:
- Autonomic reflex innervation of the head and upper CNS centers: Sympathetic outflow originates from T1–T4. Treating upper thoracic somatic dysfunction (T1–T4) and rib dysfunctions modulates sympathetic tone to the head and neck.
- Cranial osteopathy in psychotropic-induced somatic tension: Vault Hold assessment commonly demonstrates sphenobasilar synchondrosis (SBS) compression or restricted cranial rhythmic impulse (CRI) in patients suffering from severe psychomotor agitation and muscle hypertonicity. Venous sinus drainage and CV4 bulb decompression enhance autonomic equilibrium.